FSH Society

~FSH Society partners with Wellstone Muscular Dystrophy Cooperative Research Center~

"There are currently no clinical trials of novel therapeutics for FSHD ongoing in the United States because of a lack of relevant preclinical data to direct development of therapeutic targets to disease mechanisms. The Wellstone Center seeks to change that. 

'FSHD leads to severe muscle weakness and our Center's therapeutic approaches will focus on development of drugs that target disease genes, as well as drugs that improve muscle strength,' says Center Director Charles P. Emerson Jr, PhD, professor of cell & developmental biology and neurology. 'The therapeutic approaches being developed by our center will have broad application to the treatment of other muscular dystrophies and other debilitating medical conditions of muscle weakness including aging, muscle injury and confined bed rest.'"